| Nature Reviews Genetics
| [0003]
|
| BMC Genomics
| [0005]
|
| Cell
| [0006]
|
| PNAS
| [0007]
|
| Genome Biology
| [0008]
|
| Science
| [0113]
|
| Current Protocols in Molecular Biology, Current Protocols in Immunology, Current Protocols in Protein Science, and Current Protocols in Cell Biology
| [0186]
|
| Molecular Cloning: A Laboratory Manual
| [0186]
|
| Antibodies - A Laboratory Manual
| [0186]
|
| Culture of Animal Cells, A Manual of Basic Technique
| [0186]
|
| Goodman and Gilman's The Pharmacological Basis of Therapeutics
| [0186]
|
| Basic and Clinical Pharmacology
| [0186]
|
| BASIC AND CLINICAL PHARMACOLOGY
| [0186]
|
| Mendelian Inheritance in Man
| [0186]
|
| Stedman's Medical Dictionary
| [0263]
|
| J Pept Sci.
| [0321]
|
| Bioorg Med Chem Lett.
| [0334]
|
| Chembiochem
| [0336]
|
| EMBO J.
| [0338]
|
| Bioorg Med Chem Lett.
| [0341]
|
| Curr. Op. Chem. Biol.
| [0345]
|
| Proc Natl Acad Sci U S A
| [0345]
|
| Oncol Rep
| [0345]
|
| Bioorg Med Chem
| [0345]
|
| Oncogene
| [0345]
|
| Mol Cancer Ther
| [0345]
|
| Chem Biol
| [0346]
|
| ChemMedChem
| [0346]
|
| Proc Natl Acad Sci U S A
| [0346]
|
| Cell Cycle
| [0346]
|
| Annu Rev. Genet
| [0351]
|
| Mol Cancer Res.
| [0352]
|
| J Biol Chem.
| [0352]
|
| Chem Biol.
| [0353]
|
| PLos O
| [0353]
|
| Mol Cell Biol.
| [0354]
|
| Proc Natl Acad Sci USA
| [0354]
|
| Cancer: Principles and Practice of Oncology
| [0359]
|
| Goodman and Gilman's The Pharmacological Basis of Therapeutics
| [0359]
|
| Cancer Res
| [0361]
|
| Proc Nat'l Acad Sci USA
| [0361]
|
| Exp Opin Drug Deliv.
| [0362]
|
| J. Mol. Biol.
| [0362]
|
| Biochim. Biophys. Acta
| [0363]
|
| REMINGTON'S PHARMACEUTICAL SCIENCES
| [0364]
[0365]
|
| Design and implementation of high-throughput screening assays
| [0388]
|
| Introduction: cell-based assays for high-throughput screening
| [0388]
|
| High Throughput Screening: Methods and Protocols (Methods in Molecular Biology)
| [0388]
|
| High-Throughput Screening in Drug Discovery (Methods and Principles in Medicinal Chemistry)
| [0388]
|
| Current Opinion in Chemical Biology
| [0390]
|
| Current Opinion in Chemical Biology
| [0390]
|
| J. Chem. Inf. Model.
| [0390]
|
| An integrated encyclopedia of DNA elements in the human genome
| [0414]
|
| Core transcriptional regulatory circuitry in human embryonic stem cells
| [0414]
|
| Histone H3K27ac separates active from poised enhancers and predicts developmental state
| [0414]
|
| Cdx2 gene expression and trophectoderm lineage specification in mouse embryos
| [0414]
|
| Topological domains in mammalian genomes identified by analysis of chromatin interactions
| [0414]
[0522]
|
| Dissecting self-renewal in stem cells with RNA interference
| [0414]
|
| Mediator and cohesin connect gene expression and chromatin architecture
| [0414]
[0522]
[0522]
|
| The miR-290-295 cluster promotes pluripotency maintenance by regulating cell cycle phase distribution in mouse embryonic stem cells
| [0414]
|
| The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation
| [0414]
|
| Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells
| [0414]
|
| Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells
| [0414]
|
| A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells
| [0414]
|
| Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation
| [0414]
|
| Enhancer function: new insights into the regulation of tissue-specific gene expression
| [0414]
|
| A unique chromatin signature uncovers early developmental enhancers in humans
| [0414]
|
| Linking disease associations with regulatory information in the human genome
| [0414]
|
| A map of the cis-regulatory sequences in the mouse genome
| [0414]
[0522]
|
| Cdx2 is required for correct cell fate specification and differentiation of trophectoderm in the mouse blastocyst
| [0414]
|
| The accessible chromatin landscape of the human genome
| [0414]
[0522]
|
| Brgl is required for Cdx2-mediated repression of Oct4 expression in mouse blastocysts
| [0414]
|
| Classification of human genomic regions based on experimentally determined binding sites of more than 100 transcription-related factors
| [0414]
|
| Control of the embryonic stem cell state
| [0414]
[0522]
|
| Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells
| [0414]
|
| Members of the miR-290 cluster modulate in vitro differentiation of mouse embryonic stem cells
| [0414]
|
| Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription
| [0431]
|
| The enhanceosome and transcriptional synergy
| [0431]
[0522]
|
| A potent GAL4 derivative activates transcription at a distance in vitro
| [0431]
|
| Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
| [0431]
|
| BET bromodomain inhibition as a therapeutic strategy to target c-Myc
| [0431]
|
| Histone recognition and large-scale structural analysis of the human bromodomain family
| [0431]
|
| Selective inhibition of BET bromodomains
| [0431]
|
| Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions
| [0431]
|
| Cooperative DNA binding of the yeast transcriptional activator GAL4
| [0431]
|
| Regulated expression of the GAL4 activator gene in yeast provides a sensitive genetic switch for glucose repression
| [0431]
|
| Control of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation
| [0431]
|
| The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription
| [0431]
|
| Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways
| [0431]
|
| The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome
| [0431]
|
| Targeting MYC dependence in cancer by inhibiting BET bromodomains
| [0431]
|
| X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors
| [0431]
|
| Suppression of inflammation by a synthetic histone mimic
| [0431]
|
| IRF4 addiction in multiple myeloma
| [0431]
|
| Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome
| [0431]
|
| The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation
| [0431]
|
| Human mediator enhances activator-facilitated recruitment of RNA polymerase II and promoter recognition by TATA-binding protein (TBP) independently of TBP-associated factors
| [0431]
|
| Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4
| [0431]
|
| RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
| [0431]
|
| Nucleic Acids Research
| [0508]
|
| Nat. Rev. Cancer
| [0508]
|
| 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
| [0522]
[0522]
|
| Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
| [0522]
|
| The molecular genetics of cancer
| [0522]
|
| Genetics, pathogenesis and clinical interventions in type 1 diabetes
| [0522]
|
| Developmental regulation of eukaryotic gene loci: which cis-regulatory information is required?
| [0522]
[0522]
|
| Core transcriptional regulatory circuitry in human embryonic stem cells
| [0522]
|
| Functional and mechanistic diversity of distal transcription enhancers
| [0522]
|
| Modification of enhancer chromatin: what, how, and why?
| [0522]
|
| Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
| [0522]
|
| Integration of external signaling pathways with the core transcriptional network in embryonic stem cells
| [0522]
|
| Reprogramming cellular identity for regenerative medicine
| [0522]
|
| Genetics and epigenetics of systemic lupus erythematosus
| [0522]
|
| Histone H3K27ac separates active from poised enhancers and predicts developmental state
| [0522]
|
| Genetic susceptibility to systemic lupus erythematosus in the genomic era
| [0522]
|
| The human Mi-2/NuRD complex and gene regulation
| [0522]
|
| An integrated encyclopedia of DNA elements in the human genome
| [0522]
|
| A genetic model for colorectal tumorigenesis
| [0522]
|
| COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
| [0522]
[0522]
|
| A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus
| [0522]
|
| Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability
| [0522]
|
| A census of human cancer genes
| [0522]
|
| Lessons from the cancer genome
| [0522]
|
| Forcing cells to change lineages
| [0522]
|
| Identifying recent adaptations in large-scale genomic data
| [0522]
|
| Position-independent, high-level expression of the human beta-globin gene in transgenic mice
| [0522]
|
| Hallmarks of cancer: the next generation
| [0522]
|
| Histone modifications at human enhancers reflect global cell-type-specific gene expression
| [0522]
|
| Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
| [0522]
|
| Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
| [0522]
|
| An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network
| [0522]
|
| An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency
| [0522]
|
| Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer
| [0522]
[0522]
|
| The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription
| [0522]
|
| Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways
| [0522]
|
| The NuRD component Mbd3 is required for pluripotency of embryonic stem cells
| [0522]
|
| Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells
| [0522]
|
| Widespread transcription at neuronal activity-regulated enhancers
| [0522]
|
| Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters
| [0522]
[0522]
|
| Activating RNAs associate with Mediator to enhance chromatin architecture and transcription
| [0522]
|
| Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription
| [0522]
|
| Transcriptional regulation and its misregulation in disease
| [0522]
|
| Disentangling the many layers of eukaryotic transcriptional regulation
| [0522]
|
| Transcription regulation and animal diversity
| [0522]
|
| Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation
| [0522]
|
| HS2 enhancer function is blocked by a transcriptional terminator inserted between the enhancer and the promoter
| [0522]
|
| Selective inhibition of tumor oncogenes by disruption of super-enhancers
| [0522]
|
| Transcriptional regulatory elements in the human genome
| [0522]
|
| Systematic localization of common disease-associated variation in regulatory DNA
| [0522]
[0522]
|
| Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription
| [0522]
|
| eRNAs Promote Transcription by Establishing Chromatin Accessibility at Defined Genomic Loci
| [0522]
|
| Master transcription factors determine cell-type-specific responses to TGF-beta signaling
| [0522]
[0522]
|
| Noncoding transcription at enhancers: general principles and functional models
| [0522]
|
| An expansive human regulatory lexicon encoded in transcription factor footprints
| [0522]
|
| The transcriptional and signalling networks of pluripotency
| [0522]
|
| Genetics of type 1 diabetes
| [0522]
|
| Enhancer function: new insights into the regulation of tissue-specific gene expression
| [0522]
|
| Chromatin connections to pluripotency and cellular reprogramming
| [0522]
|
| Long noncoding RNAs with enhancer-like function in human cells
| [0522]
|
| The enhanceosome
| [0522]
|
| The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
| [0522]
[0522]
|
| A unique chromatin signature uncovers early developmental enhancers in humans
| [0522]
|
| NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment
| [0522]
|
| NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression
| [0522]
|
| CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression
| [0522]
|
| Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
| [0522]
|
| Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells
| [0522]
[0522]
|
| Transcription factors: from enhancer binding to developmental control
| [0522]
|
| The genetics of Alzheimer disease
| [0522]
|
| The ''beta-like-globin'' gene domain in human erythroid cells
| [0522]
|
| Personal and population genomics of human regulatory variation
| [0522]
|
| ChIP-seq accurately predicts tissue-specific activity of enhancers
| [0522]
|
| Cancer genome landscapes
| [0522]
|
| Enhancer decommissioning by LSD1 during embryonic stem cell differentiation
| [0522]
[0522]
|
| Master transcription factors and mediator establish super-enhancers at key cell identity genes
| [0522]
[0522]
|
| Developmental biology. Enhancing pluripotency and lineage specification
| [0522]
[0522]
|
| Model-based analysis of ChIP-Seq (MACS)
| [0522]
[0522]
|
| In vivo reprogramming of adult pancreatic exocrine cells to beta-cells
| [0522]
|
| Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions
| [0522]
|
| bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS
| [0522]
|
| Multiple roles and interactions of Tbx4 and Tbx5 in development of the respiratory system
| [0522]
|
| Transcription factor TEAD4 regulates expression of myogenin and the unfolded protein response genes during C2C12 cell differentiation
| [0522]
|
| Sequentially acting Sox transcription factors in neural lineage development
| [0522]
|
| Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression
| [0522]
|
| The NIH Roadmap Epigenomics Mapping Consortium
| [0522]
|
| The role of SOX10 during enteric nervous system development
| [0522]
|
| Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling
| [0522]
|
| The transcription factor Sox10 is a key regulator of peripheral glial development
| [0522]
|
| Transcriptional control of early B cell development
| [0522]
|
| T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis
| [0522]
|
| Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis
| [0522]
|
| Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-t1 cells
| [0522]
|
| Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants
| [0522]
|
| Expression of a single transfected cDNA converts fibroblasts to myoblasts
| [0522]
|
| Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells
| [0522]
|
| Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation
| [0522]
|
| Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain
| [0522]
|
| Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation
| [0522]
|
| FIMO: scanning for occurrences of a given motif
| [0522]
|
| Six 1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype
| [0522]
|
| The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation
| [0522]
|
| Direct reprogramming of fibroblasts into neural stem cells by defined factors
| [0522]
|
| Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation
| [0522]
|
| Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
| [0522]
|
| Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex
| [0522]
|
| Bach2: plasma-cell differentiation takes a break
| [0522]
|
| The human genome browser at UCSC
| [0522]
|
| Aiolos: an ungrateful member of the Ikaros family
| [0522]
|
| Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
| [0522]
|
| Identification of direct regulatory targets of the transcription factor Sox10 based on function and conservation
| [0522]
|
| The many faces of PPARgamma
| [0522]
|
| Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis
| [0522]
|
| Transcriptional amplification in tumor cells with elevated c-Myc
| [0522]
|
| Cistrome: an integrative platform for transcriptional regulation studies
| [0522]
|
| Selective inhibition of tumor oncogenes by disruption of super-enhancers
| [0522]
|
| Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b
| [0522]
|
| Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5
| [0522]
|
| Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression
| [0522]
|
| C/EBPalpha is required for lung maturation at birth
| [0522]
|
| TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes
| [0522]
|
| Transcriptional regulation of cortical neuron migration by POU domain factors
| [0522]
|
| Pax5: a master regulator of B cell development and leukemogenesis
| [0522]
|
| An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation
| [0522]
|
| Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor
| [0522]
|
| Transcription factor-induced lineage selection of stem-cell-derived neural progenitor cells
| [0522]
|
| Direct conversion of human fibroblasts to dopaminergic neurons
| [0522]
|
| NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins
| [0522]
|
| In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
| [0522]
|
| CREB activation induces adipogenesis in 3T3-L1 cells
| [0522]
|
| Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor
| [0522]
|
| PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
| [0522]
|
| Transcriptional regulation of adipogenesis
| [0522]
|
| MyoD or Myf-5 is required for the formation of skeletal muscle
| [0522]
|
| Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia
| [0522]
|
| A census of amplified and overexpressed human cancer genes
| [0522]
|
| TcoF-DB: dragon database for human transcription co-factors and transcription factor interacting proteins
| [0522]
|
| The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs
| [0522]
|
| Re-expression of GATA2 cooperates with peroxisome proliferator-activated receptor-gamma depletion to revert the adipocyte phenotype
| [0522]
|
| Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma
| [0522]
|
| Conversion of mouse and human fibroblasts into functional spinal motor neurons
| [0522]
|
| Heart repair by reprogramming non-myocytes with cardiac transcription factors
| [0522]
|
| Brn-I and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons
| [0522]
|
| Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD
| [0522]
|
| Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development
| [0522]
|
| Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene
| [0522]
|
| RSAT 2011: regulatory sequence analysis tools
| [0522]
|
| TopHat: discovering splice junctions with RNA-Seq
| [0522]
|
| GATA factors efficiently direct cardiac fate from embryonic stem cells
| [0522]
|
| GATA4 is essential for formation of the proepicardium and regulates cardiogenesis
| [0522]
|
| Molecular principles of Oct2-mediated gene activation in B cells
| [0522]
|
| Six family genes control the proliferation and differentiation of muscle satellite cells
| [0522]
|
| AnimalTFDB: a comprehensive animal transcription factor database
| [0522]
|